Wallace Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 08-12-2024
- Paid Up Capital ₹ 2.65 Cr
as on 08-12-2024
- Company Age 56 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 45.00 Cr
as on 08-12-2024
- Satisfied Charges ₹ 208.79 Cr
as on 08-12-2024
- Revenue -1.37%
(FY 2021)
- Profit 0.21%
(FY 2021)
- Ebitda 3.84%
(FY 2021)
- Net Worth 36.76%
(FY 2021)
- Total Assets 19.57%
(FY 2021)
About Wallace Pharmaceuticals
The Corporate was formerly known as Carter Wallace Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 2.65 Cr.
The company currently has active open charges totaling ₹45.00 Cr. The company has closed loans amounting to ₹208.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Cesar Menezes, Maria Menezes, Rashmi Menezes, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239GA1968PTC000080
- Company No.
000080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1968
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Wallace Pharmaceuticals Private Limited offer?
Wallace Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Health Conditions, Stomach Care, Health Food & Drinks, Healthy Snacks, Nutritional Drinks, For Adults, Skin Care, Sunscreen Products.
Who are the key members and board of directors at Wallace Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cesar Menezes  | Managing Director | 15-Jun-2005 | Current |
| Rashmi Menezes | Managing Director | 31-May-2001 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maria Menezes | Director | 09-Dec-1997 | Current |
| Naveen Gupta | Director | 27-May-2011 | Current |
| Pankaj Kumar | Director | 22-Jun-2020 | Current |
| Vinay Pinto | Director | 25-Feb-2002 | Current |
Financial Performance of Wallace Pharmaceuticals.
Wallace Pharmaceuticals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 1.37% decrease. The company also saw a slight improvement in profitability, with a 0.21% increase in profit. The company's net worth Soared by an impressive increase of 36.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wallace Pharmaceuticals?
In 2021, Wallace Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indi Pharma Private LimitedActive 40 years 11 monthsCesar Menezes and Maria Menezes are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 16 Mar 2016 | ₹45.00 Cr | Open |
Yes Bank Limited Creation Date: 28 Sep 2023 | ₹100.00 Cr | Satisfied |
Bank Of Baroda Creation Date: 31 Mar 1999 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Wallace Pharmaceuticals?
Wallace Pharmaceuticals has a workforce of 1788 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wallace Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wallace Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
